A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
Clinical trial NCT05744921 · RECRUITING
Trial details
- NCT number
- NCT05744921
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2028-10-10
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.